...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products:(Date:10/15/2008)...sity and Delta Dental Foundation project is workin... Indiana children, INDIANAPOLIS, Oct. 15 /PRNewsw...olis area schools seen between January and Septemb...ry mobile project had moderate or,severe dental de...am operated by the,university and funded in part b...
(Date:10/15/2008)... American Bishops regarding ,Catholic moral teachi...c teaching of the Catholic Church..." concerni...INGTON, Oct. 15 /PRNewswire-USNewswire/ -- The fol...Operation Rescue, Washington DC., The "Open Lette...ail to,all U.S. Bishops. (See complete letter at ...
(Date:10/15/2008)... Nonprofit Cenegenics Education and Researc...ors from the University of Miami - Miller School o...owth hormone normalization in proven clinically de...ion and quality of life. Favorable findings from p...urnal of Multidisciplinary Healthcare, part of Dov...
(Date:10/15/2008).... A multicenter team of researchers, including sc...vered a way to potentially block the growth of neu...rcent of all cancer deaths in children. , Workin...chers describe in Thursday,s (Oct. 16, 2008) onlin...rcuit genetic processes that apparently contribute...
Breaking Medicine News(10 mins):Health News:SEAL Indiana Reports More Than Half of Indianapolis Area School Kids Treated by Program Have Moderate or Severe Dental Decay 2Health News:Breaking News: Finally! A Catholic Bishop Confirms that a Catholic Cannot Vote for Obama in Good Conscience 2Health News:Hormone Normalization Shows Encouraging Effects In Documented Clinically Deficient Men/Women 2Health News:Hormone Normalization Shows Encouraging Effects In Documented Clinically Deficient Men/Women 3Health News:Scientists close in on method to fight deadly childhood cancer 2Health News:Scientists close in on method to fight deadly childhood cancer 3(Date:10/13/2008)...)-F Surface Treatment Maximizes,Endothelialization...ng-Term,Dual Antiplatelet Therapy, WASHINGTON, Oc...day,s,"Innovative Devices and Futuristic Therapies...diovascular Therapeutics (TCT) scientific,symposiu...tion, presented,12-month follow-up data from the A...
(Date:10/13/2008)...e Cancer Populations Facilitates ... 13 /- Rubicon Genomics, Inc. today,a...fy DNA samples for The,Cancer Atlas Genome Project...tandardize total genomic,DNA from 3,000 tissue and...enomePlex(TM) Whole Genome Amplification technolog...
(Date:10/12/2008)...ts designed for more uniform drug ...NGTON, Oct. 12 /- Boston,Sc... comprehensive data from,the TAXUS ATLAS clinical ...nter, single-arm, historically controlled trials, ...Eluting Stent System in a variety of,lesions and p...
(Date:10/10/2008)...wire/ -- Diplomat Specialty,Pharmacy announced tod...ecialty Pharmacy to be one of only three sites to ...imization Study for Multiple Sclerosis (TOP MS)., ...mine the benefits of a,specialty pharmacy therapy ...tient outcomes. Targeted patient outcomes will inc...
Breaking Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 1AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits 14970 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 1Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 2Cantel Medical Corp and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic 14968 3WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 1WellPoints Health Plans to Cover Newly Approved Cancer Treatment 14966 2Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 1Stress On The Campaign Trail One Issue All The Candidates Agree On 14964 2...SINESS WIRE)--May 17, 2007 - Salix,Pharmaceuticals...of,18 investigator-initiated trials related to the... Disease Week(R) 2007, which will be,held May 19-2...largest and most prestigious meeting in the world ...re than 16,000 physicians,researchers and academi...
...SIS 301012 produced at least 45% additional,reduct...imally-tolerated lipid-lowering therapies, CARLSBA...Isis,Pharmaceuticals, Inc. announced updated resul... 301012 in patients with homozygous,familial hyper...ere,presented in March at the of Cardiology Annual...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5